Koldamova, Radosveta
- University of Pittsburgh · Public Health (NIH department code)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
FY2022 NIH rank #1,804
- R01 Holder
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2014 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award categories
- Public Health
NIH Funding · FY2022
Linked Award Amount
$2.9M
Full award amounts, FY2022
Award Records
2
Records listing this PI
Award-Linked Rank
#1,804
By linked amount among FY2022 PIs
Earliest Year Loaded
2014
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2022 award records by amount
NIH award records listing Koldamova, Radosveta as a PI. Multi-PI records show the full award amount for context.
- 1RF1AG075992-01A1RF1Contact PIncRNAs in plasma EVs of AD patients and their discriminatory power as biomarkersUniversity of Pittsburgh · Public Health (NIH department code)$2.3Maward amount
- 5R01AG057565-05R01Contact PIAPOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2University of Pittsburgh · Public Health (NIH department code)$635.9Kaward amount
Award organization
Organizations that administered FY2022 awards listing Koldamova, Radosveta as a PI.
FY2022 award administered by University of Pittsburgh (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2014First NIH AwardUniversity of Pittsburgh
- 2014$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2017$2M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #1451
- 2017Entered Top 25% NationallyRanked #1451
- 2017Entered Top 10% NationallyRanked #1451
- 2017R01 Grant Holder
- 2018$5M Cumulative Funding
- 2022$10M Cumulative Funding